SEC Comment Letter 0000000000-22-013793 to PaxMedica, Inc. (PXMD) (CIK 0001811623)
PaxMedica, Inc. (PXMD) (CIK 0001811623)
Date: Dec. 21, 2022 · CIK: 0001811623 · Accession: 0000000000-22-013793
AI Filing Summary & Sentiment
File numbers found in text: 333-268882
Letter
United States securities and exchange commission logo December 21, 2022 Howard J. Weisman Chief Executive Officer PaxMedica, Inc. 303 South Broadway, Suite 125 Tarrytown, NY 10591 Re:PaxMedica, Inc. Registration Statement on Form S-1 Filed December 19, 2022 File No. 333-268882 Dear Howard J. Weisman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Anna Tomczyk, Esq.
Show Raw Text
United States securities and exchange commission logo
December 21, 2022
Howard J. Weisman
Chief Executive Officer
PaxMedica, Inc.
303 South Broadway, Suite 125
Tarrytown, NY 10591
Re:PaxMedica, Inc.
Registration Statement on Form S-1
Filed December 19, 2022
File No. 333-268882
Dear Howard J. Weisman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Anna Tomczyk, Esq.